ArticleActa neuropathologica communications2024
Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022).
Open access · goldAbstract readLetterComment
In one paragraph
Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
32 authors at 12 institutions in 10 countries.
Huihui LuoDepartment of Neuromuscular Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Emil K GustavssonDepartment of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
Hannah MacphersonDepartment of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
Natalia DominikDepartment of Neuromuscular Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Kristina ZhelcheskaDepartment of Neuromuscular Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Kylie MontgomeryDepartment of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
Claire AndersonDepartment of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
Wai Yan YauThe Perron Institute for Neurological and Translational Science, Perth, Australia.
Stephanie EfthymiouDepartment of Neuromuscular Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Chris TurnerThe National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Michael DeTureDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Keith A JosephsNeurodegenerative Research Group, Mayo Clinic, Rochester, MN, USA.
Tamas ReveszQueen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, London, UK.
Tammaryn LashleyQueen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, London, UK.
Glenda HallidayNeuroscience Research Australia, Sydney, Australia.
Dominic B RoweCentre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Emily McCannCentre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Ian BlairCentre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Andrew J LeesQueen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, London, UK.
Pentti J TienariDepartment of Neurology, Helsinki University Hospital, Helsinki, Finland.
Anu SuomalainenResearch Programs Unit, Stem Cells and Metabolism, University of Helsinki, 00290, Helsinki, Finland.
Laura Molina-PorcelAlzheimer's Disease and Other Cognitive Disorders Unit. Neurology Service, Hospital ClínicFundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomediques August Pi I Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.
Gabor G KovacsTanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Canada.
Ellen GelpiDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
John HardyDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, UCL, London, UK.
Matti J HaltiaDepartment of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Arianna TucciWilliam Harvey Research Institute, Queen Mary University of London, London, UK.
Zane JaunmuktaneQueen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, London, UK.
Mina RytenDepartment of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
Henry HouldenDepartment of Neuromuscular Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Zhongbo ChenDepartment of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK. zhongbo.chen@ucl.ac.uk.ORCID 0000-0001-6668-7202
National Hospital for Neurology and Neurosurgery · GBGreat Ormond Street Hospital · GBQueen Mary University of London · GBMacquarie University · AUUniversity of Helsinki · FIMayo Clinic in Florida · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESMayo Clinic · USMedical University of Vienna · ATPerron Institute for Neurological and Translational Science · AUThe University of Sydney · AUUniversity of Toronto · CA
Funding
Medical Research Council MR/N008324/1Medical Research Council MR/S006753/1Medical Research Council MR/S01165X/1
Abstract
PubMed holds no abstract for this paper.
Indexed as
Intranuclear Inclusion BodiesNeurodegenerative DiseasesHumansHornerinNeuronal intranuclear inclusion diseaseRepeat expansion disorders
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.